Device Trial Radar · NCT02660645
Blue Light Cystoscopy With Cysview® Registry
Last checked: Nov 20, 2026Latest source record: Dec 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
4,400
Planned (sponsor's estimate)
Start
Apr 2014
Primary completion
Dec 2028
Study completion Dec 2028
Sponsor
- Lead sponsor
- PhotocureNot on our public-company list
- Sponsor type
- Industry
- Collaborators
- Catalyst Pharmaceutical Research
- First posted
- Jan 21, 2016
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Registry study to gather more information on the current use of Blue Light Cystoscopy with Cysview (BLCC) in urologists' practices.
Conditions
- Bladder Cancer
Interventions
Hexaminolevulinate hydrochloride (HCL)Drug
Instillation in bladder
Karl Storz D-Light C Photodynamic Diagnostic (PDD) systemDevice
Cystoscopy procedure
Primary outcomes
What the sponsor says the trial is designed to measure.
- Rate of detection of bladder malignanciesTime frame: 5 years
Locations
23 sites in 1 country. Site status is shown where the registry gives one.
The University of Alabama at Birmingham
Birmingham, Alabama · Recruiting
Mayo Clinic
Phoenix, Arizona · Recruiting
USC/Norris Comprehensive Cancer Center
Los Angeles, California · Recruiting
20 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.